Location History:
- München, DE (2017)
- Munich, DE (2021)
Company Filing History:
Years Active: 2017-2021
Title: David Ott: Innovator in Antibody Technology
Introduction
David Ott is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic rodent antibody libraries. His work has implications for various applications in research and medicine.
Latest Patents
David Ott holds two notable patents. His latest invention focuses on rodent combinatorial antibody libraries. This invention provides synthetic rodent antibody libraries, such as mouse or rat antibody libraries, along with polypeptides, nucleic acids, vectors, host cells, and methods used in conjunction with these libraries. Additionally, the invention includes antibodies isolated from such libraries and variants of these antibodies.
Career Highlights
David Ott is associated with Morphosys AG, a leading biotechnology company. His role at Morphosys AG has allowed him to work on cutting-edge research and development projects that advance the field of antibody technology.
Collaborations
David collaborates with esteemed colleagues, including Josef Prassler and Stefanie Thiel. Their combined expertise contributes to the innovative environment at Morphosys AG.
Conclusion
David Ott's work in synthetic rodent antibody libraries showcases his commitment to advancing biotechnology. His contributions are vital for the development of new therapeutic solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.